(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid
95%
- Product Code: 236772
CAS:
1821775-88-5
Molecular Weight: | 418.44 g./mol | Molecular Formula: | C₂₄H₂₂N₂O₅ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, drying away from light |
Product Description:
Used in peptide synthesis as a protected amino acid derivative, particularly in the preparation of biologically active compounds and pharmaceutical intermediates. The Fmoc group allows for solid-phase synthesis by providing temporary N-terminal protection that is easily removed under mild basic conditions. The methoxypyridine moiety can act as a ligand or structural component in drug design, especially in kinase inhibitors or receptor modulators. Its chiral center ensures stereoselective incorporation into target molecules, making it valuable in the development of enantiomerically pure therapeutics. Commonly employed in research settings for synthesizing peptide-based drugs with enhanced stability and binding affinity.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿4,390.00 |
+
-
|
0.250 | 10-20 days | ฿7,450.00 |
+
-
|
1.000 | 10-20 days | ฿20,100.00 |
+
-
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(6-methoxypyridin-3-yl)propanoic acid
Used in peptide synthesis as a protected amino acid derivative, particularly in the preparation of biologically active compounds and pharmaceutical intermediates. The Fmoc group allows for solid-phase synthesis by providing temporary N-terminal protection that is easily removed under mild basic conditions. The methoxypyridine moiety can act as a ligand or structural component in drug design, especially in kinase inhibitors or receptor modulators. Its chiral center ensures stereoselective incorporation into target molecules, making it valuable in the development of enantiomerically pure therapeutics. Commonly employed in research settings for synthesizing peptide-based drugs with enhanced stability and binding affinity.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :